Researchers evaluated whether a deep learning model could distinguish between autoimmune neuroinflammatory disorders based on retinal thickness.
At ASTRO, Artera presented clinical validation data on its prostate cancer test in an Asian population,and showed how the test may complement gene expression-based approaches.